Sunday |
4:00 pm - 8:00 pm | Arrival and Check-in |
6:00 pm | Dinner |
7:30 pm - 7:40 pm | Welcome / Introductory Comments by GRC Site Staff |
7:40 pm - 9:30 pm | Keynote Session: Transglutaminases: Multifaceted Enzymes with Multiple Roles in Disease Processes |
| Discussion Leader: Timothy Johnson (UCB, United Kingdom) |
7:40 pm - 7:50 pm | Opening Remarks |
7:50 pm - 8:15 pm | Mauro Piacentini (University of Rome Tor Vergata, Italy) "The Many Faces of Transglutaminases in Disease Processes" |
8:15 pm - 8:20 pm | Discussion |
8:20 pm - 8:45 pm | Kapil Mehta (University of Texas, USA) "Potential Therapeutic Approaches to Manipulating Transglutaminases in Disease Processes" |
8:45 pm - 8:55 pm | Discussion |
8:55 pm - 9:20 pm | Benjamin Drukarch (VU University Medical Center, The Netherlands) "PET Imaging and Its Possible Application in Assessing TG2 Activity" |
9:20 pm - 9:30 pm | Discussion |
Monday |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Modulators, Structures and Substrates of Transglutaminases |
| Discussion Leader: Jeffrey Keillor (University of Ottawa, Canada) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Christopher Clouthier (University of Ottawa, Canada) "A Parallel Assessment of TG Conformation and Activity by CE Mass Spec Ion Mobility" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Laszlo Fesus (University of Debrecen, Hungary) "Comparative and Population Genomics Data Reveal Strong Evolutionary Pressure on Structure and Functions of Transglutaminase 2" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Brad Palanski (Stanford University, USA) "Activation of Extracellular TG2" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Muriel Maurer (University of Louisville, USA) "Mass Spectrometry and NMR Approaches for Measuring the Specificity of FXIII Towards Its Substrates" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:20 pm | Candace Kerr (University of Maryland, USA) "The Inhibition of Transglutaminase Activity in Cancer Stem Cells: Relationship to Conformational Changes and GTP Binding" |
12:20 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
3:00 pm - 4:00 pm | Power Hour |
| The GRC Power Hour is an optional informal gathering open to all meeting participants. It is designed to help address the challenges women face in science and support the professional growth of women in our communities by providing an open forum for discussion and mentoring. |
| Organizer: Mari Kaartinen (McGill University, Canada) |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | The Function of Transglutaminases in Cardiovascular Disease |
| Discussion Leader: Dan Berkowitz (Johns Hopkins University, USA) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Kelly Beazley (University of Maryland, USA) "New Approaches to Arterial Calcification Through TG2 and Beta-Catenin" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Erik Bakker (Academic Medical Center, The Netherlands) "TG2 and Vascular Mechanotransduction" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Lakshmi Santhanam (Johns Hopkins School of Medicine, USA) "TG2:
Separating the Cross Linking-Dependent and Independent Activities in Vascular Disease" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Tuesday |
7:30 am - 8:30 am | Breakfast |
8:30 am | Group Photo |
9:00 am - 12:30 pm | Transglutaminases in Tissue Remodeling, Fibrosis and Scarring |
| Discussion Leader: Patricia Sime (University of Rochester Medical Center, USA) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Martin Griffin (Aston University, United Kingdom) "A New Strategic Approach to the Treatment of Cardiac Fibrosis (CF) Based on Small-Molecule Inhibitors of TG2" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Elisabetta Verderio (Nottingham Trent University, United Kingdom) "Is Targeting the Transglutaminase-2-Syndecan 4 Interaction a Viable Anti-Fibrotic Strategy?" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:25 am | Krishna Penumatsa (Tufts Medical Center, USA) "TG2 and Pulmonary Hypertension" |
11:25 am - 11:35 am | Discussion |
11:35 am - 11:55 am | Timothy Johnson (UCB, United Kingdom) "Application of TG2 Inhibitory Antibodies in Treating Kidney Fibrosis: A Translational Perspective" |
11:55 am - 12:00 pm | Discussion |
12:00 pm - 12:10 pm | Selected from Poster Abstracts: Nicole McNeil (University of Ottawa, Canada) "Novel Irreversible Inhibitors of Human Tissue Transglutaminase" |
12:10 pm - 12:15 pm | Discussion |
12:15 pm - 12:25 pm | Selected from Poster Abstracts: Thomas Thatcher (University of Rochester, USA) "Contrasting Pro- and Anti-Fibrotic Roles for Tissue Transglutaminase (TG2) in Lung Fibroblasts and Epithelial Cells" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | Do Transglutaminases Play a Role in Immunology and Rheumatology? |
| Discussion Leader: Riccardo Ientile (University of Messina, Italy) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Zsuzsa Szondy (University of Debrecen, Hungary) "Loss of Transglutaminase 2 Sensitizes for the Development of Various Chronic Inflammatory Diseases" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Daniela Caccamo (University of Messina, Italy) "Different Transglutaminase Isoforms in Cell Response to Inflammatory Stimuli" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Patrick Schloss (Central Institute of Mental Health, Mannheim, Heidelberg University, Germany) "Serotonin – More than a Neurotransmitter – TGase-Mediated Serotonylation in Blood and Brain" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Wednesday |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | What Role Do Transglutaminases Play in Neurological Disease? |
| Discussion Leader: Anne-Marie Van Dam (VU University Medical Center, The Netherlands) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Scott Brady (University of Illinois at Chicago, USA) "Transglutaminase and Neuronal Functioning" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | M. Maral Mouradian (Robert Wood Johnson Medical School, Rutgers University, USA) "Transglutaminase 2 in Parkinson's Disease" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Micha Wilhelmus (VU University Medical Center, The Netherlands) "Transglutaminase 2 in Alzheimer's Diseasse" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Daniel Aeschlimann (Cardiff University, United Kingdom) "Transglutaminase 6 in Relation to Neurological Dysfunction" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:05 pm | Selected from Poster Abstracts: Navina Chrobok (VU University Medical Center Amsterdam, The Netherlands) "Can Effects of Tissue Transglutaminase Inhibition on the Outcome of a Mouse Model for Multiple Sclerosis Be Attributed to Extracellular TG2?" |
12:05 pm - 12:10 pm | Discussion |
12:10 pm - 12:25 pm | Selected from Poster Abstracts: Christian Recktenwald (University of Gothenburg, Sweden) "Tissue Transglutaminase but Not Epidermal Transglutaminase Is Required for the Formation of a Bacteria-Impenetrable Mucus Layer" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | Celiac Disease, Gastroenterology and Transglutaminases |
| Discussion Leader: Katri Lindfors (University of Tampere, Finland) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Ludvig Sollid (University of Oslo, Norway) "TG2 Autoantibody Response in Celiac Disease" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Aaron Lerner (Technion - Israel Institute of Technology, Israel / Aesku.Kipp Institute, Germany) "Microbial Transglutaminase Is a New Bio-Marker and a Potential Inducer of Celiac Disease" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Renato Monteiro (Center for Research on Inflammation, Université Paris Diderot, France) "Transglutaminase
2 and Gluten: Essential Pivots in the Pathogenesis of IgA Nephropathy" |
7:50 pm - 8:00 pm | Discussion |
8:00 pm | Dinner |
Thursday |
7:30 am - 8:30 am | Breakfast |
8:30 am - 9:00 am | Business Meeting |
| Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair |
9:00 am - 12:30 pm | Transglutaminases in Oncology |
| Discussion Leader: Daniela Matei (Northwestern University, USA) |
9:00 am - 9:20 am | Introduction by Discussion Leader |
9:20 am - 9:45 am | Richard Eckert (University of Maryland School of Medicine, USA) "Transglutaminases in Skin Cancer Stem Cells" |
9:45 am - 9:55 am | Discussion |
9:55 am - 10:20 am | Wenguo Jiang (Cardiff University School of Medicine, United Kingdom) "TG4 and Prostate Cancer" |
10:20 am - 10:30 am | Discussion |
10:30 am - 11:00 am | Coffee Break |
11:00 am - 11:15 am | Salvatore Condello (Northwestern University, USA) "TG2-FN-Integrin Complex in Ovarian Cancer Stem Cells" |
11:15 am - 11:20 am | Discussion |
11:20 am - 11:45 am | Federica Rossin (University of Rome Tor Vergata, Italy) "How Does TG2 Participate in Bioenergetic Metabolism" |
11:45 am - 11:55 am | Discussion |
11:55 am - 12:05 pm | Selected from Poster Abstracts: Uwe Ackermann (Austin Health, Australia) "Imaging of TG2 Activity in Breast Cancer Using Radiolabelled Hitomi Peptides" |
12:05 pm - 12:10 pm | Discussion |
12:10 pm - 12:25 pm | Selected from Poster Abstracts: Magdalena Adamczyk (Cardiff University, United Kingdom) "The Emerging Role of TG2 During Early Osteoarthritis" |
12:25 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:30 pm | Free Time |
4:30 pm - 6:00 pm | Poster Session |
6:00 pm - 8:00 pm | The Contribution of Transglutaminases to Connective Tissue Disorders |
| Discussion Leader: Mari Kaartinen (McGill University, Canada) |
6:00 pm - 6:20 pm | Introduction by Discussion Leader |
6:20 pm - 6:45 pm | Matthew Flick (Cincinnati Children's Hospital Medical Center, USA) "FXIII-A and Arthritis and Bone Erosion" |
6:45 pm - 6:55 pm | Discussion |
6:55 pm - 7:15 pm | Huifang Sun (Faculty of Dentistry, McGill University, Canada) "Transglutaminases, Bone Resorption and Osteoclastogenesis" |
7:15 pm - 7:25 pm | Discussion |
7:25 pm - 7:50 pm | Martine Charbonneau (Université de Sherbrooke, Canada) "TG2, Invadopodia and Cartilage Breakdown" |
7:50 pm - 7:55 pm | Discussion |
7:55 pm - 8:00 pm | Closing Remarks |
8:00 pm | Dinner |
Friday |
7:30 am - 8:30 am | Breakfast |
9:00 am | Departure |